Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Breast Inflammatory Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00162812
What this trial is testing

Topoisomerase II Alpha Gene Amplification and Protein Overexpression Predicting Efficacy of Epirubicin

Who this might be right for
Breast Cancer
Jules Bordet Institute 338
Not applicableActive Not RecruitingNCT04030507
What this trial is testing

Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer

Who this might be right for
Breast CancerHER2-positive Breast CancerTriple Negative Breast Cancer+3 more
Brigham and Women's Hospital 214
Large-scale testing (Phase 3)Study completedNCT00017095
What this trial is testing

Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 1,856
Large-scale testing (Phase 3)Active Not RecruitingNCT02221999
What this trial is testing

Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients

Who this might be right for
Tubular Breast CancerMucinous Breast CancerInvasive Ductal Breast Cancer+1 more
RenJi Hospital 250
Not applicableLooking for participantsNCT03941756
What this trial is testing

Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma

Who this might be right for
Anatomic Stage III Breast Cancer AJCC v8Breast Inflammatory CarcinomaLocally Advanced Breast Carcinoma+1 more
M.D. Anderson Cancer Center 252
Testing effectiveness (Phase 2)Study completedNCT01036087
What this trial is testing

Panitumumab, Nab-paclitaxel and Carboplatin for HER2 Negative Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Ended earlyNCT01938833
What this trial is testing

Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer

Who this might be right for
HER2-negative Breast CancerInflammatory Breast CancerMale Breast Cancer+2 more
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 9
Not applicableLooking for participantsNCT07080944
What this trial is testing

Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in IBC

Who this might be right for
Invasive Breast CarcinomaSentinel Lymph Node Biopsy (SLNB)Neoadjuvant Chemotherapy
European Institute of Oncology 75
Large-scale testing (Phase 3)UnknownNCT00003680
What this trial is testing

Standard Chemotherapy Compared With High-Dose Chemotherapy Plus Peripheral Stem Cell Transplant in Treating Women With Advanced or Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
Scottish Cancer Therapy Network 300
Testing effectiveness (Phase 2)Study completedNCT00513695
What this trial is testing

Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer

Who this might be right for
Inflammatory Breast CancerMale Breast CancerStage II Breast Cancer+3 more
University of Washington 68
Large-scale testing (Phase 3)UnknownNCT00003679
What this trial is testing

Combination Chemotherapy in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
Scottish Cancer Therapy Network 350
Testing effectiveness (Phase 2)Active Not RecruitingNCT01525966
What this trial is testing

Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer

Who this might be right for
Inflammatory Breast CancerStage IIA Breast CancerStage IIIA Breast Cancer+7 more
City of Hope Medical Center 67
Testing effectiveness (Phase 2)Ended earlyNCT00756470
What this trial is testing

Phase II Neoadjuvant in Inflammatory Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center 15
Testing effectiveness (Phase 2)UnknownNCT00957125
What this trial is testing

A Translational Trial on Molecular Markers and Functional Imaging to Predict Response of Preoperative Treatment of Breast Cancer Early

Who this might be right for
Breast Cancer
Thomas Hatschek 151
Early research (Phase 1)WithdrawnNCT05093387
What this trial is testing

SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Breast Inflammatory CarcinomaMetastatic Triple-Negative Breast Carcinoma+1 more
Northwestern University
Testing effectiveness (Phase 2)Study completedNCT01730833
What this trial is testing

Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer

Who this might be right for
HER2-positive Breast CancerRecurrent Breast CancerStage IIA Breast Cancer+7 more
City of Hope Medical Center 63
Testing effectiveness (Phase 2)Study completedNCT02556632
What this trial is testing

Prophylactic Topical Agents in Reducing Radiation-Induced Dermatitis in Patients With Non-inflammatory Breast Cancer

Who this might be right for
Breast CarcinomaPainRadiation-Induced Dermatitis+1 more
Gary Morrow 191
Not applicableUnknownNCT00005058
What this trial is testing

Enhanced Ultrasound in Determining Extent of Disease in Women With Primary Breast Cancer

Who this might be right for
Breast Cancer
Royal Marsden NHS Foundation Trust
Testing effectiveness (Phase 2)Ended earlyNCT05041101
What this trial is testing

Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer

Who this might be right for
Breast Inflammatory CarcinomaRecurrent Breast Inflammatory CarcinomaStage IV Breast Inflammatory Carcinoma
M.D. Anderson Cancer Center 6
Early research (Phase 1)Ended earlyNCT00004261
What this trial is testing

EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma

Who this might be right for
Breast CancerCervical CancerHead and Neck Cancer+2 more
University Health Network, Toronto
Next Page